These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32742479)
1. Serum Exosomal miR-941 as a promising Oncogenic Biomarker for Laryngeal Squamous Cell Carcinoma. Zhao Q; Zheng X; Guo H; Xue X; Zhang Y; Niu M; Cui J; Liu H; Luo H; Yang D; Shi Y; Huangfu H; Wen S; Wu Y; Gao W; Wang B J Cancer; 2020; 11(18):5329-5344. PubMed ID: 32742479 [TBL] [Abstract][Full Text] [Related]
2. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764 [TBL] [Abstract][Full Text] [Related]
3. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC). Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255 [TBL] [Abstract][Full Text] [Related]
4. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs. Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753 [TBL] [Abstract][Full Text] [Related]
5. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-632 is a potential marker for the diagnosis and prognosis in laryngeal squamous cell carcinoma. Cao YC; Song LQ; Xu WW; Qi JJ; Wang XY; Su Y Acta Otolaryngol; 2020 May; 140(5):418-421. PubMed ID: 32068453 [No Abstract] [Full Text] [Related]
7. miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression. Zhong G; Xiong X Biol Res; 2015 Oct; 48():60. PubMed ID: 26515287 [TBL] [Abstract][Full Text] [Related]
8. Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma. Teng Y; Kang H; Chu Y Genet Test Mol Biomarkers; 2019 Apr; 23(4):235-240. PubMed ID: 30986097 [TBL] [Abstract][Full Text] [Related]
9. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma. Wang JL; Wang X; Yang D; Shi WJ Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma. Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793 [TBL] [Abstract][Full Text] [Related]
11. Serum Exosomal miR-223 Serves as a Potential Diagnostic and Prognostic Biomarker for Dementia. Wei H; Xu Y; Xu W; Zhou Q; Chen Q; Yang M; Feng F; Liu Y; Zhu X; Yu M; Li Y Neuroscience; 2018 May; 379():167-176. PubMed ID: 29559383 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31. Yang S; Wang J; Ge W; Jiang Y J Cell Biochem; 2018 Aug; 119(8):6953-6960. PubMed ID: 29737563 [TBL] [Abstract][Full Text] [Related]
13. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis. Tian L; Cao J; Jiao H; Zhang J; Ren X; Liu X; Liu M; Sun Y Clin Sci (Lond); 2019 May; 133(9):1053-1066. PubMed ID: 30992382 [No Abstract] [Full Text] [Related]
14. miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1β. Chang K; Wei Z; Cao H Oncol Lett; 2020 Oct; 20(4):80. PubMed ID: 32863913 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1. Gao W; Wu Y; He X; Zhang C; Zhu M; Chen B; Liu Q; Qu X; Li W; Wen S; Wang B J Cancer; 2017; 8(12):2356-2368. PubMed ID: 28819440 [No Abstract] [Full Text] [Related]
16. MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1. Ge W; Han C; Wang J; Zhang Y Am J Transl Res; 2016; 8(9):3903-3911. PubMed ID: 27725869 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
18. Exosomal MicroRNA-223, MicroRNA-146, and MicroRNA-21 Profiles and Biochemical Changes in Laryngeal Cancer. Genc S; Yagci T; Vageli DP; Dundar R; Doukas PG; Doukas SG; Tolia M; Chatzakis N; Tsatsakis A; Taghizadehghalehjoughi A ACS Pharmacol Transl Sci; 2023 May; 6(5):820-828. PubMed ID: 37200807 [TBL] [Abstract][Full Text] [Related]
19. MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1. Wang J; Yang S; Ge W; Wang Y; Han C; Li M J Cell Biochem; 2018 Jul; 119(7):5118-5125. PubMed ID: 29091303 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MIR100HG promotes cancer cell proliferation, migration and invasion in laryngeal squamous cell carcinoma through the downregulation of miR-204-5p. Huang Y; Zhang C; Zhou Y Onco Targets Ther; 2019; 12():2967-2973. PubMed ID: 31114240 [No Abstract] [Full Text] [Related] [Next] [New Search]